New York State Common Retirement Fund Moon Lake Immunotherapeutics Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$38.43 - $48.6 $312,282 - $394,923	-8,126 Reduced 98.31%	140 $6,000
Q1 2024 May 07, 2024	BUY	$43.78 - $63.86 $357,901 - $522,055	8,175 Added 8983.52%	8,266 $415,000
Q4 2023 Feb 01, 2024	SELL	$36.35 - $63.02 $2,689 - $4,663	-74 Reduced 44.85%	91 $5,000
Q2 2023 Aug 07, 2023	BUY	$19.01 - $51.79 $3,136 - $8,545	165 New	165 $8,000

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.92B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.